The patent a covers the technology in combination with Carbidopa and Levodopa - currently in a Phase III trial for advanced Parkinson's disease - until April 2029. The Accordion Pill fits inside a standard size capsule, and is composed of a multi-layer, planar structure, reminiscent of an accordion.
Read more:
https://www.in-pharmatechnologist.com/Article/2018/01/04/Intec-gets-Canadian-patent-for-Accordion-Pill-controlled-release-tech?
UNABLE TO COPY, BECAUSE OF COPYRIGHT.
No comments:
Post a Comment